Jason Breen

BridgeBio Pharma’s $2.45 Billion Collaboration and Licensing Agreement with Helsinn Group

By Martina Bellini

Goodwin Procter LLP advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) and its affiliate QED Therapeutics, Inc. announced a global collaboration and licensing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Northwestern Mutual Capital’s $473 Million Fund VII Closing

US Department Of Energy’s $861.3 Million Financing for Solar Energy Projects in Puerto Rico

Jefferies Finance’s $1.95 Billion Bank and Bond Financing

YPF Luz’s US$420 Million Notes Issuance

360 Energy Solar’s US$22 Million Green Notes Issuance

Eneva’s Acquisition of Tevisa Termelétrica Viana, Povoação Energia, Linhares Brasil Energia Participações, and 50% of Geradora de Energia do Maranhão

Sosteneo’s Refinancing Of 100MW Richborough Energy Park BESS

Freight Investor Services’ Dispute In Court Of Geneva and Lausanne

Zorlu Enerji’s US$200 Million Sustainability-Linked Eurobond Issuance

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Camusat Holding’s €81 Million Mezzanine Investment Round

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Lulu Retail Holdings Plc’s $1.72 Billion IPO On ADX

AGC Automotive (Thailand) Co., Ltd. v. Renewable Energy for Thai People Co., Ltd.

Profectus Capital’s Non-Convertible Debentures Issuance

NBL and LK Group’s Investment in WNBL

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Leading Healthcare and Life Sciences Attorney Craig Bleifer Joins McGuireWoods

Hogan Lovells Bolsters International Arbitration Practice with Strategic Hire of Rob Palmer in Singapore

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Leading Healthcare and Life Sciences Attorney Craig Bleifer Joins McGuireWoods

Hogan Lovells Bolsters International Arbitration Practice with Strategic Hire of Rob Palmer in Singapore

BridgeBio Pharma’s $2.45 Billion Collaboration and Licensing Agreement with Helsinn Group

Standard 1 Year Membership Required